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Yousef and colleagues’ article discussing the value of 
monitoring serum leptin in critically ill patients touches 
on the important matter of early diagnosis and diﬀ  eren-
tiation between sepsis and non-infectious systemic 
inﬂ  am  matory response syndrome (SIRS) [1]. Th  e early 
diagnosis of sepsis, the identiﬁ  cation of its origin, and an 
adequate therapeutic management are crucial to 
overcome sepsis-associated mortality [2].
Cytokine levels are the obvious choice as sepsis markers 
since cytokines are key mediators of the inﬂ  ammatory 
response to sepsis. Among the cytokines, TNFα, IL-1, 
IL-6, IFNγ, IL-10, and IL-13 best characterize the 
immune dysregulation during sepsis [3].
In 1998 Bornstein and colleagues reported an increase 
in leptin levels and the loss of the diurnal rhythm of this 
adipokine in survivors of acute sepsis [4]. Th  ey also 
observed that low leptin and high IL-6 levels indicated an 
unfavorable prognosis in patients with sepsis syndrome. 
Owing to contradictory ﬁ  ndings in latter reports [5-9], 
however, the interest in leptin as a sepsis marker waned.
Leptin, a hormone mainly generated by adipocytes, 
acts centrally in the hypothalamus to regulate body 
weight and energy expenditure. Th   ere is, however, strong 
evidence that leptin is also involved in cell-mediated 
immunity and cytokine crosstalk [10].
Yousef and colleagues conﬁ  rmed a positive correlation 
between leptin and IL-6 and TNFα in patients with sepsis 
[11]. Th  e  ﬁ  nding that a serum leptin threshold of 38 μg/l 
can distinguish between sepsis and non-infectious SIRS 
(sensitivity 91.2%, speciﬁ  city 85%) is the major ﬁ  nding in 
the article  by Yousef and colleagues (in this issue).
Th   e matter at heart in the early diﬀ  erentiation between 
sepsis and non-infectious SIRS is the impact on outcome. 
In patients with surgically conﬁ  rmed  secondary 
peritonitis, our group found that a serum level of leptin 
<10 ng/ml was accompanied by a 4.25-fold increase in 
the risk of death. Our results were limited to moderate to 
severe peritonitis where the measurement was made 
24 hours into the postoperative period (±2 hours) [12]. 
Since leptin apparently inhibits an excessive or harmful 
lipopolysaccharide-induced inﬂ  ammatory reaction to or 
prevents TNFα-induced lethality in sepsis [13], it would 
have been interesting if Yousef and colleagues had 
reported the results of the 11 patients that died in their 
study group [1]. Our ﬁ   ndings [12] concur with those 
reported by Bornstein and colleagues: an increase is 
found in leptin serum levels in septic patients, while a 
low leptin level is associated with a negative outcome [4] – 
possibly due to the lack of the protective eﬀ  ect of leptin 
[13].
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colleagues (in this issue). Much remains to be learned 
about the precise mechanisms by which leptin 
signaling participates in sepsis and non-infectious 
SIRS. This knowledge will potentially contribute to new 
therapeutic approaches.
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